Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
$86.28
Merck & Company (MRK): Building Strength, Paving the Way for Potential Upside
31 Oct 2025, 11:49
Chart & Data from IG
Accenture’s share price is currently trading at around $255.37, with technical indicators signalling that the stock may be oversold in the near term. Based on historical patterns and market momentum, there is a strong case for a potential rebound towards the $280 level over the coming weeks.
On the weekly chart, Accenture shares are sitting near the lower Bollinger Band, following a period of consolidation. Historically, when Accenture’s price moves into this zone, a rally often follows in subsequent weeks. This technical setup suggests that buyers may soon regain control, pushing the price higher.
Key indicators also reinforce this bullish outlook:
RSI (Relative Strength Index): Sitting in oversold territory.
MACD (Moving Average Convergence Divergence): Near reversal levels.
Stochastic Oscillator: Signalling oversold conditions.
Together, these tools suggest that the recent selling pressure may be exhausted, creating room for a short-term upside move.
The stock has recently tested the January 2021 support level, an area where buyers have stepped in multiple times before. Unless Accenture breaks below $236, the technical case for a bounce remains valid.
On the upside, the $280 price target aligns with the moving average of the Bollinger Bands, making it a realistic near-term objective.
While short-term risks remain, Accenture’s current price action indicates that the stock may be undervalued at these levels. With multiple technical indicators confirming oversold conditions, traders and investors could see a reversal and bullish momentum build in the weeks ahead.